Micheletti Talita, Eixarch Elisenda, Febas Germán, Berdun Sergio, Parra Johanna, Hernansanz Albert, Borrós Salvador, Gratacos Eduard
BCNatal Fetal Medicine Research Center (Hospital Clínic Barcelona and Hospital Sant Joan de Déu Barcelona), University of Barcelona, Barcelona, Spain (Drs Micheletti, Eixarch, Berdun, Parra, and Gratacos); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (Drs Micheletti, Eixarch, and Gratacos).
BCNatal Fetal Medicine Research Center (Hospital Clínic Barcelona and Hospital Sant Joan de Déu Barcelona), University of Barcelona, Barcelona, Spain (Drs Micheletti, Eixarch, Berdun, Parra, and Gratacos); Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain (Drs Micheletti, Eixarch, and Gratacos); Centre for Biomedical Research on Rare Diseases (CIBER-ER), Madrid, Spain (Drs Eixarch and Gratacos).
Am J Obstet Gynecol MFM. 2022 May;4(3):100593. doi: 10.1016/j.ajogmf.2022.100593. Epub 2022 Feb 7.
Preterm prelabor rupture of membranes is the most frequent complication of fetoscopic surgery. Strategies to seal the membrane defect created by fetoscopy have been attempted with little success. We previously developed an integrated semirigid bioadhesive patch composed of silicone and hydroxypropyl methylcellulose that achieved ex vivo sealing of membrane defects.
To evaluate the feasibility of the insertion of our integrated semirigid bioadhesive patches using a fetoscopic technique and to test the adhesion in ex vivo human membranes and in an in vivo ovine model.
An experimental study involving 2 experiments: (1) ex vivo-human fetal membranes were mounted in a custom-designed model with saline solution simulating intraamniotic pressure. The insertion of 2 different bioadhesive patches made of silicone-hydroxypropyl methylcellulose and silicone-polyurethane-hydroxypropyl methylcellulose was performed through a 12-Fr cannula mimicking fetoscopic surgery technique. The experiment was repeated 10 times with membranes from different donors. Measures included insertion time, successful insertion, and adhesion at 5 minutes; (2) in vivo-16 patches of silicone-hydroxypropyl methylcellulose were inserted by fetoscopy in the amniotic cavity of pregnant sheep (4 bioadhesives per animal, in 4 ewes). Measures included successful insertion, adhesion at 5 minutes, and adhesion at the end of surgery.
In the ex vivo insertion study, there was no difference in the insertion time between silicone-hydroxypropyl methylcellulose and silicone-polyurethane-hydroxypropyl methylcellulose patches (P=.49). Insertion was successful in all cases, but complete adhesion at 5 minutes was superior for silicone-hydroxypropyl methylcellulose (P=.02). In the in vivo study, insertion of silicone-hydroxypropyl methylcellulose by fetoscopy was feasible and successful in all cases, and no complications were reported. Adhesion persisted at 5 minutes and at the end of the surgery in 68.8% and 56.3% of the patches, respectively.
We describe the feasibility of deploying through a fetoscopic trocar a semirigid silicone-hydroxypropyl methylcellulose patch that seals fetal membranes after an invasive fetal procedure. The results warrant further research for improving long-term adhesion and developing a clinically applicable system.
胎膜早破是胎儿镜手术最常见的并发症。人们尝试了多种策略来封闭胎儿镜造成的胎膜缺损,但收效甚微。我们之前研发了一种由硅胶和羟丙基甲基纤维素组成的一体化半刚性生物粘附贴片,该贴片在体外实现了对胎膜缺损的封闭。
评估使用胎儿镜技术插入我们的一体化半刚性生物粘附贴片的可行性,并测试其在体外人胎膜和体内绵羊模型中的粘附力。
一项包含两个实验的实验性研究:(1)将人胎儿胎膜置于一个定制设计的模型中,用生理盐水模拟羊膜腔内压力。通过一根模仿胎儿镜手术技术的12F套管插入由硅胶 - 羟丙基甲基纤维素和硅胶 - 聚氨酯 - 羟丙基甲基纤维素制成的两种不同生物粘附贴片。使用来自不同供体的胎膜重复该实验10次。测量指标包括插入时间、成功插入情况以及5分钟时的粘附力;(2)在体内——通过胎儿镜将16片硅胶 - 羟丙基甲基纤维素贴片插入怀孕绵羊的羊膜腔(每只动物插入4片生物粘附贴片,共4只母羊)。测量指标包括成功插入情况、5分钟时的粘附力以及手术结束时的粘附力。
在体外插入研究中,硅胶 - 羟丙基甲基纤维素贴片和硅胶 - 聚氨酯 - 羟丙基甲基纤维素贴片的插入时间没有差异(P = 0.49)。所有情况下插入均成功,但5分钟时的完全粘附情况硅胶 - 羟丙基甲基纤维素贴片更优(P = 0.02)。在体内研究中,通过胎儿镜插入硅胶 - 羟丙基甲基纤维素贴片在所有情况下均可行且成功,且未报告并发症。分别有68.8%和56.3%的贴片在5分钟和手术结束时仍保持粘附。
我们描述了通过胎儿镜套管部署一种半刚性硅胶 - 羟丙基甲基纤维素贴片的可行性,该贴片在侵入性胎儿手术后可封闭胎膜。这些结果值得进一步研究以改善长期粘附力并开发一种临床适用的系统。